Matthew Mulvey PhD

Dr. Mulvey is an inventor on all BeneVir patents. He has eight years of experience in the biotechnology industry at Sequella, Inc., a clinical stage anti-infectives company. While at Sequella, Dr. Mulvey invented and patented a diagnostic technology, obtained NIH funding to support its advancement, and participated in a partnering effort that culminated in licensing of the technology to a major clinical diagnostics company. In addition, he participated in the design and execution of clinical trials for a diagnostic product and was involved in the development of Sequella’s antibiotic pipeline.